or Try an Advanced Search...

    Technical Analysis for INDV - Indivior PLC

    Grade Last Price % Change Price Change
    F 9.35 3.77% 0.34
    INDV closed up 3.77 percent on Friday, November 1, 2024, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical INDV trend table...
    Date Alert Name Type % Chg
    Weak + Overbought Other 0.00%
    Wide Bands Range Expansion 0.00%
    Overbought Stochastic Strength 0.00%
    Weak + Overbought Other 3.77%
    Wide Bands Range Expansion 3.77%
    Overbought Stochastic Strength 3.77%
    Gapped Down Weakness 3.77%
    Pocket Pivot Bullish Swing Setup 0.54%
    Stochastic Reached Overbought Strength 0.54%
    Weak + Overbought Other 0.54%
    Older End-of-Day Signals for INDV ...

       Recent Intraday Alerts

    Alert Time
    Up 3% about 21 hours ago
    Rose Above Previous Day's High about 24 hours ago
    Up 2% about 24 hours ago
    Up 1% about 24 hours ago
    Down 1 ATR 2 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    INDV Chart by TradingView
    Basic chart:

    Profile

    Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet. The company operates in approximately 40 countries worldwide. It has collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Drugs Psychoactive Drugs Euphoriants Opioids Schizophrenia Morphinans Drug Rehabilitation Opioid Use Disorder Buprenorphine Sodium Channel Blockers

    Is INDV a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 17 Two Seas Capital LP Increases Stake in Indivior PLC
    Oct 7 Indivior's SUBLOCADE® Rapid Induction/Alternative Injection Site Prior Approval Supplement (PAS) Receives FDA Priority Review
    Sep 25 Rigel (RIGL) Surges 19.7%: Is This an Indication of Further Gains?
    Sep 23 Top 3 Health Care Stocks That May Explode This Month
    Sep 6 Smith & Wesson Brands Reports Downbeat Results, Joins Planet Labs PBC, Broadcom And Other Big Stocks Moving Lower In Friday's Pre-Market Session
    Sep 5 French Biotech Candidate For Cannabis Use Disorder Fails Phase 2B Clinical Trial, Indivior Will Not Exercise Option
    Sep 4 Indivior Provides Update on Aelis Farma's Clinical Phase 2B Study Results with AEF0117 in Participants with Cannabis Use Disorder
    Aug 28 Addex Stock Soars on Crucial Update From Indivior Research Deal
    Aug 27 Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder
    Jul 28 Wall Street Breakfast: The Week Ahead
    See more INDV news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 23.22
    52 Week Low 7.33
    Average Volume 1,033,912
    200-Day Moving Average 15.30
    50-Day Moving Average 9.81
    20-Day Moving Average 8.77
    10-Day Moving Average 8.91
    Average True Range 0.45
    RSI (14) 52.38
    ADX 17.27
    +DI 27.88
    -DI 24.65
    Chandelier Exit (Long, 3 ATRs) 9.13
    Chandelier Exit (Short, 3 ATRs) 8.69
    Upper Bollinger Bands 10.14
    Lower Bollinger Band 7.39
    Percent B (%b) 0.71
    BandWidth 31.41
    MACD Line -0.17
    MACD Signal Line -0.34
    MACD Histogram 0.1703
    Fundamentals Value
    Market Cap 1.29 Billion
    Num Shares 138 Million
    EPS -0.40
    Price-to-Earnings (P/E) Ratio -23.38
    Price-to-Sales 0.00
    Price-to-Book 0.00
    Dividend 0.00
    Dividend Yield 0.00%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 9.84
    Resistance 3 (R3) 9.80 9.60 9.76
    Resistance 2 (R2) 9.60 9.47 9.62 9.73
    Resistance 1 (R1) 9.47 9.40 9.54 9.51 9.70
    Pivot Point 9.27 9.27 9.30 9.29 9.27
    Support 1 (S1) 9.15 9.15 9.21 9.19 9.00
    Support 2 (S2) 8.95 9.07 8.97 8.97
    Support 3 (S3) 8.82 8.95 8.94
    Support 4 (S4) 8.86